SCHEDULE 2U.K.Applications in respect of pharmaceutical lists and the procedures to be followed

PART 5U.K.Notification, taking effect of decisions and rights of appeal to the Secretary of State

[F1Template notice of consolidationU.K.

29A.—(1) This paragraph applies as regards a notice of decision under paragraph 28 in respect of a consolidation application that is granted, in relation to the person who is—

(a)P1 for the purposes of regulation 26A (P1), if regulation 26A(3) applied to that application; or

(b)P2 for the purposes of regulation 26A (P2), if regulation 26A(4) applied to that application.

(2) [F2NHS England] must send with the notice of decision sent to P1 or P2 a template of a notice of consolidation, for P1 or P2 to send to it under paragraph 34A, in which P1 or P2 is to provide the following information (some of which [F2NHS England] may have included in the template that it sends)—

(a)the date of the grant of the application;

(b)the address of the premises at which pharmaceutical services are no longer to be provided (“the closing premises”);

(c)the date on which pharmaceutical services are to cease being provided at the closing premises;

(d)the address of the premises at which pharmaceutical services are to continue to be provided (“the continuing premises”);

(e)the registration number of the continuing premises with the General Pharmaceutical Council;

(f)confirmation that reasonable steps have been taken to advise any patients who have nominated the person listed in relation to the closing premises as their nominated dispensing contractor that their nomination will transfer to the person listed in relation to the continuing premises, if the Electronic Prescription Service is available through those premises, unless they change their nomination;

(g)the date on which the consolidation is to take effect;

(h)a signature on behalf of P1 or P2 (whichever has been sent the template) and the date of the notice.]